Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges
- PMID: 36523312
- PMCID: PMC9745375
- DOI: 10.21037/tcr-22-2158
Therapeutic vaccines for human papillomavirus-related cancer: progress and challenges
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-22-2158/coif). The authors have no conflicts of interest to declare.
Comment on
-
Optimal long peptide for flagellin-adjuvanted HPV E7 cancer vaccine to enhance tumor suppression in combination with anti-PD-1.Transl Cancer Res. 2022 Jun;11(6):1595-1602. doi: 10.21037/tcr-21-2798. Transl Cancer Res. 2022. PMID: 35836530 Free PMC article.
References
-
- World Health Organization [Internet]. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020 - [cited 2022 Aug 31]. Available online: https://www.who.int/publications/i/item/9789240014107
-
- Sert BM, Kristensen GB, Kleppe A, et al. Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience. Gynecol Oncol 2021;162:284-91. 10.1016/j.ygyno.2021.05.028 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources